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The ability of DNA tumor virus proteins to trigger apoptosis in mammalian cells is well established. For
example, transgenic expression of a simian virus 40 (SV40) T-antigen N-terminal fragment (N-termTag) is
known to induce apoptosis in choroid plexus epithelial cells. SV40 T-antigen-induced apoptosis has generally
been considered to be a p53-dependent event because cell death in the brain is greatly diminished in a p532/2
background strain and is abrogated by expression of wild-type (p53-binding) SV40 T antigen. We now show
that while N-termTags triggered apoptosis in rat embryo fibroblasts cultured in low serum, expression of
full-length T antigens unable to bind p53 [mut(p532)Tags] protected against apoptosis without causing
transformation. One domain essential for blocking apoptosis by T antigen was mapped to amino acids 525 to
541. This domain has >60% homology with a domain of adenovirus type 5 E1B 19K required to prevent
E1A-induced apoptosis. In the context of both wild-type T antigen and mut(p532)Tags, mutation of two
conserved amino acids in this region eliminated T antigen’s antiapoptotic activity in REF-52 cells. These data
suggest that SV40 T antigen contains a novel functional domain involved in preventing apoptosis indepen-
dently of inactivation of p53.
Apoptosis is a morphologically distinct form of cell death
which represents an important mechanism for regulation of
cellular proliferation. The discovery that the most common
chromosomal translocation found in B-cell follicular lympho-
mas results in the overexpression of the antiapoptotic bcl-2
gene product (3, 38) underscores the importance of apoptosis
in regulating cellular growth. Presumably, Bcl-2 overexpression
allows the outgrowth of abnormal cells which otherwise would
be eliminated by apoptosis. More recently, a family of bcl-2-
related viral and cellular genes which can modulate apopto-
sis (7, 25) has been described; additional gene families
whose products also inhibit apoptosis have been identified
(8, 15, 34).
Apoptosis has also been shown to be a common host cell
response to a wide variety of viral infections, and many viruses,
in turn, produce proteins which inhibit apoptosis. Among the
small DNA tumor viruses, recent evidence indicates that ex-
pression of the adenovirus E1A protein (13), the human pap-
illomavirus (HPV) E7 protein (17, 26), or an N-terminal frag-
ment of the large T antigen (Tag) of simian virus 40 (SV40)
(N-termTag) (35) can induce apoptosis in rodent cells of epi-
thelial origin. All of these viral proteins are able to bind to and
inactivate pRb, p107, and p130 but not affect directly the ac-
tivities of p53. This discovery is consistent with the more gen-
eral observation that disruption of normal cellular growth con-
trol pathways (in this case, inactivation of the pRb family of
proteins) can trigger apoptosis (1, 20, 27). Interestingly, ex-
pression of adenovirus E1A, HPV E7, and SV40 N-termTag in
p532/2 knockout mouse cells has been shown to cause trans-
formation and limit apoptosis. This finding is consistent with
the known antiapoptotic functions associated with those DNA
tumor virus proteins known to inactivate p53 function: adeno-
virus E1B 55K, HPV E6, and the carboxyl half of SV40 Tag.
However, the most potent antiapoptotic viral protein identified
thus far, the adenovirus E1B 19K protein, does not interact
directly with p53 and is able to overcome both p53-dependent
(41) and -independent (22) E1A-induced apoptosis.
The domains of SV40 Tag involved in preventing apoptosis
have not been directly studied. However, based on the finding
that choroid plexus epithelial cells from p531/1 (but not
p532/2) mice undergo apoptosis when an N-TermTag is ex-
pressed, protection has been assumed to involve those regions
of Tag that bind to and inactivate p53 (35). Consistent with
this, we previously found that three domains of Tag, the ex-
treme N terminus (amino acids [aa] 1 to 82), the pRb family
binding region (aa 105 to 113), and the p53 binding region (aa
350 to 450 and 540 to 708), are all required to immortalize
primary mouse embryo fibroblasts (MEFs) (11). However, we
also observed that full-length mutant Tags defective for p53
binding [mut(p532)Tags] neither immortalized nor induced ap-
optosis in MEFs; rather MEFs expressing mut(p532)Tags
ceased proliferation with a characteristic senescent morphol-
ogy. The differing fates of cells expressing mut(p532)Tags ver-
sus N-termTags suggested the existence of a novel antiapop-
totic activity in the full-length protein. In this study, we
identified a functional region of T antigen which protects
against apoptosis independently of p53 binding and inactiva-
tion. Interestingly, this region includes a short, 16-aa domain
(aa 525 to 541) which has greater than 60% amino acid ho-
mology with a domain of adenovirus type 5 (Ad5) E1B 19K
previously shown to be essential for preventing adenovirus
E1A-induced apoptosis. In quantitative studies, expression of
full-length SV40 Tags bearing changes at two conserved amino
acids in this region resulted in significantly decreased viability
of the rat embryo fibroblast (REF) cell line REF-52; further-
more, these cells died with a characteristic apoptotic morphol-
ogy. Moreover, decreased viability was observed when these
single amino acid mutations were introduced not only into
mut(p532)Tags but also in an otherwise wild-type Tag (i.e., p53
binding) background. Thus, we have identified a novel anti-
apoptotic domain which contributes to SV40 Tag’s oncogenic
function independently of p53 binding.
* Corresponding author. Mailing address: Department of Biochem-
istry, Dartmouth Medical School, Hanover, NH 03756. Phone: (603)
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FIG. 1. (A) Functional regions of Tag. The regions of SV40 Tag required for initiation of cellular DNA synthesis and immortalization of primary MEFs are
represented by hatched bars. Full-length mutant Tags which are defective for p53 binding (inA409 and inA424) because of small linker insertions at aa 409 or 424 are
illustrated; mutants unable to bind p53 because of a truncation upstream of the p53-binding domain (T1-138 1 6 and T1-147) or a misfolded carboxyl half (dlA2433,
lacking aa 587 to 589) are also shown. WT, wild type. (B) Cellular morphology of control MEFs transfected with pSV2neo alone (A), cells expressing mutant Tags (B
and C), and cells expressing wild-type Tag (D). Early-passage C57BL/6 MEFs were transfected at passage 0 or 1 with the neomycin resistance plasmid pSV2neo, with
or without a plasmid encoding a truncated or full-length mutant of SV40 Tag or wild-type Tag. Representative fields (magnification, 340) are shown in phase contrast
and following DAPI staining to detect DNA morphology.
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MATERIALS AND METHODS
Plasmids and generation of stable cell lines. Primary REFs were harvested
from day 12 to 16 C57BL/6 mouse or Fisher rat embryos as described previously
(11). REF-52 cells were a kind gift of Jim Pipas (University of Pittsburgh). All
cells were maintained in Dulbecco’s modification of Eagle’s minimal essential
medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum
(FCS), penicillin (50 U/ml), and streptomycin (50 mg/ml) (Gibco/BRL, Grand
Island, N.Y.). SV40 plasmids inA2809 (insert of 4 aa at aa 409; also called inA409
in this report), inA2811 (insert of 4 aa at aa 424; also called inA424 in this report)
(45), dlA2433 (deletion of aa 587 to 589), inA2420 (expresses aa 1 to 138 plus 6
additional aa) (9), T147 (expresses aa 1 to 147) (30), Ad5 E1A (42), and
pSV2neo (31) have been described previously (Fig. 1A). The new mutant plas-
mids WT/528MS, in409/528MS, in424/528MS, WT/539AD, in409/539AD, and
in424/539AD were generated by using conditions suggested by the manufacturer
of the PCR-based, site-directed mutagenesis QuikChange kit (Stratagene, La
Jolla, Calif.). The upper primer used for the methionine-to-serine mutation at aa
528 was 59-CCCTGGAATAGTCACCTCGAATGAGTACAGTGTGCC-39,
and the lower primer was 59-GGCACACTGTACTCATTCGAGGTGACTATT
CCAGGG-39; the upper primer used for the alanine-to-aspartic acid mutation at
aa 539 was 59-GCCTAAAACACTGCAGGACAGATTTGTAAAAC-39, and
the lower primer was 59-GTTTTACAAATCTGTCCTGCAGTGTTTTAGGC-
39. Putative mutagenized plasmids were screened by restriction enzyme diges-
tion. Mutations were confirmed by using the sequencing primers 59-GGCTCTG
CTGACATAGAAGAATGG-39 and 59-GCCACAGGTCTGTACCAAATTAA
CATAAGAAGC-39 in the ABI PRISM Dye Terminator Cycle Sequencing
method (Perkin-Elmer, Branchburg, N.J.) according to the manufacturer’s in-
structions. Double-stranded fluorescent sequencing was performed with an ABI
DNA sequencer at the Dartmouth Molecular Biology Core Facility.
For generating cells expressing various Tags or other proteins, primary rodent
fibroblasts or REF-52 cells were seeded at 105 cells per 10-cm-diameter plate the
day prior to calcium phosphate transfection; 48 h later, medium containing 400
mg of G418 per ml was added to cultures. Individual G418-resistant clones were
selected 21 days later and either fixed and stained with 49,6-diamidino-2-phe-
nylindole (DAPI) to reveal DNA morphology (primary cells) or subcloned for
further experiments.
Immunofluorescence and DAPI staining. Cells were seeded in 15-mm-diam-
eter wells on Teflon-coated glass slides (Cel-line, Newfield, N.J.) and allowed to
adhere. The following day, cells were washed twice with phosphate-buffered
saline (PBS), and fresh DMEM containing 0.5 or 10% FCS was added to each
well. Four days later, cells were washed twice with PBS and fixed in freshly
prepared (4%, wt/vol) paraformaldehyde. After 15 min at room temperature,
cells were washed with PBS and the primary antibody (Tag antigen monoclonal
antibody [MAb] 419 and E1A MAb M73 [a gift of Ed Harlow, Massachusetts
General Hospital Cancer Center, Boston, Mass.]) was added at a 1:10 dilution in
PBS containing 10% goat serum. Slides were incubated in a humid chamber for
1 h at 37°C and then rinsed three times in PBS–10% goat serum. Fluorescein
isothiocyanate (FITC)-labeled goat anti-mouse immunoglobulin G antiserum
(Gibco/BRL) diluted 1:200 in PBS–10% goat serum was then added to the wells
for 40 min at 37°C. The cells were washed three times with PBS and then
incubated with DAPI (1 mg/ml [final concentration] in PBS) for 1 min. Cells were
washed once more with PBS, and cover slips were mounted with Vectashield
mounting medium (Vector Laboratories, Burlingame, Calif.). Slides were exam-
ined on a Zeiss Axiophot microscope at a magnification of 3400.
Primary cells were examined in essentially the same manner except that all
staining was done in Falcon 10-cm-diameter tissue culture dishes in order to
maintain colony and individual cellular morphology of cells undergoing apopto-
sis or senescence. Cells were photographed with a Nikon inverted microscope at
a magnification of 340.
In situ DNA fragmentation assay. Apoptotic cells were detected by using an
Apoptag in situ detection kit (Oncor, Gaithersburg, Md.). Briefly, cells were
allowed to adhere to Teflon-coated slides in duplicate 15-mm-diameter wells.
The next day, cells were washed twice with Tris-buffered saline (TBS), and
DMEM containing either 10 or 0.5% FCS was added to each well. After 4 days,
the assay was performed according to the manufacturer’s instructions except that
the cells were stained with DAPI (1 mg/ml in PBS) for 1 min prior to the final
rinse. Slides were allowed to air dry, mounted with Vectashield, and observed
and photographed with a Zeiss Axiophot microscope.
Western analysis and immunoprecipitations. For Western blot analyses, cells
were washed twice with ice-cold PBS and then lysed with 1 ml of cold EBC buffer
(50 mM Tris-HCl [pH 8.0], 100 mM NaCl, 0.5% Nonidet P-40). Protein con-
centrations were determined by the Pierce colorimetric protein assay (Pierce,
Rockland, Ill.), and 10 mg of total cellular protein was added to 53 sodium
dodecyl sulfate loading buffer, boiled for 3 min, and electrophoresed on a 4 to
20% precast gradient gel (Bio-Rad, Hercules, Calif.). Following transfer to
nitrocellulose, the blot was blocked for 1 h in 5% nonfat milk–PBS and probed
with either MAb 419 (against SV40 Tag), PAb240 (against p53), a-p21 (N-20)-G
(Santa Cruz Biochemicals, Santa Cruz, Calif.), or a-Bax (N-20)-G (against Bax)
(Santa Cruz). The blots were rinsed with PBS–0.1% Tween 20 (Sigma, St. Louis,
Mo.) and incubated with an appropriate secondary horseradish peroxidase-con-
jugated anti-mouse or anti-rabbit antibody (Amersham) diluted 1:5,000 in 5%
milk–PBS. Following four additional rinses in PBS–0.1% Tween 20, blots were
developed by using chemiluminescence (Amersham).
Immunoprecipitations were performed by labeling 6.25 3 105 cells/10-cm-
diameter tissue culture dish with 100 mCi of 35S Express protein labeling mix
(NEN/Dupont) per ml for 90 min in methionine-free medium containing 2.5%
dialyzed FCS (Gibco/BRL). Cells were lysed in 1 ml of ice-cold EBC, the cellular
debris was removed by centrifugation, and lysates were precleared by using 40 ml
of protein A-Sepharose beads (Pharmacia Biotech Inc.) suspended in a 1:1 ratio
with TBS containing 10% bovine serum albumin (TBS-BSA) on a rotator at 4°C.
Following centrifugation, the supernatants were transferred to clean tubes and
incubated with 100 ml of MAb 419 (tissue culture supernatant) for 90 min, 40 ml
of protein A-Sepharose beads (1:1 in TBS-BSA) was added, and the mixture was
incubated overnight on a rotator at 4°C. The following day, the beads were
collected by centrifugation, washed three times with ice-cold PBS, and resus-
pended in 40 ml of 13 sodium dodecyl sulfate sample buffer. Samples were
boiled, subjected to electrophoresis on a 12% polyacrylamide gel, and visualized
by fluorography.
Viability assays. Cells were seeded at subconfluent densities in six-well plates
and allowed to adhere overnight. The following day, wells were washed twice
with PBS, and fresh DMEM containing 0.5 or 10% FCS was added. After 2, 4,
and 6 days, floating cells were removed along with medium, and adherent cells
were trypsinized. Cells were pooled and then centrifuged. The pellet was resus-
pended in 0.4% trypan blue solution (Sigma), and the percentage of cells that did
not take up the dye was determined by two observers. At least 200 cells were
counted for each time point in each experiment.
RESULTS
Primary REFs expressing mut(p532)Tags undergo senes-
cence, while expression of N-termTags results in apoptosis.
Previous work in our and other laboratories has demonstrated
that mut(p532)Tag expression is unable to immortalize or ex-
tend the life span of primary rodent fibroblasts (11, 21, 37, 44).
A diagram representing some of these immortalization-defi-
cient full-length and truncated Tags is shown in Fig. 1A. Pri-
mary MEFs expressing a representative N-termTag, inA2420
(T1-138 1 6), formed colonies which, at the time of control
(not transfected) cell senescence, contained cells which (i)
were dramatically smaller than senescing cells, (ii) often failed
to survive as long as senescing cells because they rounded up
and died, and (iii) exhibited nuclear morphology (shrunken
nuclei with chromatin condensation) characteristic of apopto-
sis (Fig. 1B, panel B). In contrast, primary cells expressing a
mut(p532)Tag (inA2809/inA409) ceased cell division with a se-
nescent morphology identical to that seen with control cells
(reference 11 and Fig. 1B, panels A and C). Wild-type Tag-
expressing cells formed dense colonies of small, adherent, and
rapidly dividing cells which were inevitably immortal (Fig. 1B,
panel D). Similar results were obtained when primary REFs
expressing mut(p532)Tags were studied, although the time (and
number of population doublings) prior to control cell senes-
cence was greater in REFs than in MEFs (data not shown).
REF-52 cells expressing N-termTags undergo increased cell
death with the morphological characteristics of apoptosis. To
study quantitatively the apoptosis induced by Tag, the REF-52
cell line was used to generate early-passage stable cell clones
expressing either full-length or truncated SV40 Tags defective
for p53 binding. Although immortalized, the REF-52 line has
the same genetic requirements for SV40 Tag-induced trans-
formation as primary REFs (32, 46) and has been used exten-
sively for DNA tumor virus studies (19). REF-52 cells were
transfected with N-termTag-expressing plasmid inA2420, (T1-
138 1 6), T147dl or T147Ddl (encodes aa 1 to 147, either with
or without small t antigen, respectively), or dlA2433, a mutant
with a misfolded carboxyl half due to a deletion of aa 587 to
589 (Fig. 1A). Mutant dlA2433 has been previously shown to
encode a protein which is completely defective for several
carboxyl-region T-antigen functions, including ATP binding
and ATPase activity (9), oligomerization, and p53 binding (37,
44), and is not recognized by anti-Tag MAbs directed against
conformationally sensitive determinants located within the car-
4538 CONZEN ET AL. J. VIROL.
boxyl half of Tag (10). Early-passage, stable clones expressing
full-length or truncated Tags able to bind pRb, p107, and p130
but defective for p53 binding were generated and tested for
appropriately sized Tag expression by Western blotting (Fig.
2A).
In REF-52 cells and many other cell lines, low-serum con-
ditions have been shown to induce apoptosis in cells receiving
apoptotic stimuli, whereas cells maintained in high serum
(10%) do not display significant levels of apoptosis (18, 19, 28).
To quantitatively examine the viability of early-passage
REF-52 cell lines expressing N-termTags, trypan blue dye ex-
clusion assays were performed on cells grown in medium con-
taining either 10 or 0.5% FCS. Figure 2B shows that the via-
bility of REF-52 cells expressing N-termTags was significantly
diminished in 0.5% FCS; however, in cells expressing
mut(p532)Tag (inA2409/inA409 or inA2411/inA424), viability
was similar to that of cells expressing wild-type Tag or to the
G418-resistant parental REF-52 cell line. Moreover, in
REF-52 cells expressing N-termTags, DAPI staining 48 h fol-
lowing serum depletion revealed shrunken nuclei and chroma-
tin condensation characteristic of apoptosis; this morphology
was not seen in REF-52 cells expressing mut(p532)Tags, the
parental REF-52 cell line, or wild-type Tag (Fig. 3). Expression
of small t antigen did not affect viability or nuclear morphology
of cells expressing N-termTag (data not shown). In sum, the N
terminus of Tag was able to induce apoptosis when this region
was expressed alone in REF-52 cells deprived of serum. In
FIG. 2. (A) Western blot analysis of mutant Tags. SV40 mutant Tags ex-
pressed in early-passage REF-52 cell lines were detected by using anti-Tag MAb
419, specific for the amino terminus of Tag. WT, wild type. (B) Viability of
REF-52 cells expressing truncated and full-length mutant Tags. Viability was
determined for floating and adherent cells cultured in DMEM–0.5% FCS by
trypan blue exclusion and is expressed as a percentage of the total number of
cells counted. A minimum of 200 cells was counted for each time point, and the
experiment was repeated at least three times with individually derived cell lines,
with similar results.
FIG. 3. Indirect immunofluorescence of Tag expression and nuclear mor-
phology of REF-52 cells expressing truncated or full-length mutant Tags. Early-
passage REF-52 cells expressing either truncated (top row of each panel) or
full-length (second row) mutant SV40 Tags were grown in DMEM–0.5% FCS for
4 days. Neomycin-resistant REF-52 cells (third row) and wild-type (WT) Tag-
expressing cells (fourth row) and are shown as negative controls for apoptosis.
Cells expressing adenovirus E1A (bottom row) are shown as a positive control
for induction of apoptosis. Cells were fixed and then stained with MAb 419 and
FITC-labeled goat anti-mouse immunoglobulin G to detect Tag or M73 to detect
E1A and subsequently stained with DAPI to detect DNA. Arrows indicate
apoptotic cells in T1-138 1 6- and E1A-expressing cells. The same field of cells
was photographed with appropriate filters to permit detection of FITC or DAPI.
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contrast, this activity appeared to be suppressed when the N
terminus was part of a full-length Tag, even in linker insertion
mutants unable to bind p53.
Induction of apoptosis by N-termTags does not alter the
expression of p53, p21Waf1/Cip1, or Bax. By analogy with ade-
novirus E1A expression, in which apoptosis is accompanied by
an increase in p53 protein levels, induction of apoptosis by
N-termTags but not by mut(p532)Tags suggested a possible
difference in the abilities of the two classes of mutants to
stabilize p53. Induction of apoptosis has also been associated
with alterations in the levels of two other potentially relevant
apoptosis-related proteins, p21Waf1/Cip1 and Bax. Alternatively,
if apoptosis induced by an N-termTag is independent of p53
activity, one might not see a difference in p53 protein levels or
the levels of p21Waf1/Cip1 and Bax. Figure 4A shows that while
p53 levels were stabilized in wild-type Tag-expressing cells
(lane 1), p53 levels remained barely detectable in REF-52 cells
expressing either mut(p532)Tags (lanes 2 and 3) or N-termTags
(lanes 4 to 6), as determined by Western analysis. These find-
ings suggest that there was no appreciable change in p53 pro-
tein levels compared with that of the parental cell line.
[35S]methionine pulse-chase labeling of cell lines followed by
immunoprecipitation with an anti-p53 antibody confirmed a
lack of change in p53 half-life as a consequence of expression
of mut(p532)Tags (data not shown). This result suggests that
intracellular p53 protein levels do not modulate SV40 Tag-
induced apoptosis.
Since the absence of a detectable increase in p53 protein
levels does not rule out a change in p53 transcriptional activity
(2), we examined the protein products of two p53 transcrip-
tional target genes: the cyclin-dependent kinase inhibitor
p21Waf1/Cip1 and the death-promoting Bcl-2 homolog Bax.
p21Waf1/Cip1 levels were greatly reduced following expression
of wild-type Tag (Fig. 4B, lane 1), presumably due to Tag’s
sequestration of p53 and inactivation of its transcriptional ac-
tivity (Fig. 4B, lane 1). In contrast, the level of p21Waf1/Cip1 was
clearly greater than the level found in parental REF-52 cells
following expression of either the mut(p532)Tags (Fig. 4B,
lanes 2 and 3) or N-termTags (Fig. 4B, lanes 4 to 6). This result
suggests that p21Waf1/Cip1 induction may be occurring in a
p53-dependent manner, presumably in response to a pertur-
bation of normal cell cycle control mechanisms following in-
activation of pRb family members by these mutant Tags. How-
ever, despite the uniform induction of increased p21Waf1/Cip1
protein levels in cells expressing either N-termTags or
mut(p532)Tags inA2409/inA409 and inA2411/inA424, apopto-
sis was seen only in cells expressing the Tag fragments, sug-
gesting that induction of p21Waf1/Cip1 does necessarily accom-
pany the apoptotic response. This finding is consistent with a
recent report that p21Waf1/Cip1 induction can affect cell cycle
arrest but does not induce apoptosis (6).
To investigate another potentially relevant protein encoded
by a p53-inducible gene (16), the levels of cellular Bax were
examined (Fig. 4C). Bax is a Bcl-2 homolog and heterodimer-
ization partner known to promote cell death (25); in some cell
FIG. 4. Expression p53, p21Waf1/Cip1, and Bax protein levels in REF-52 cells
expressing truncated or full-length mutant Tags. The level of p53 expression was
determined by Western blot analysis using MAb 240; p21Waf1/Cip1 and Bax levels
were detected by using polyclonal anti-rabbit antisera against amino-terminal
peptides of each protein. WT, wild type.
FIG. 5. Amino acid sequence homology of SV40 large Tag, human Bcl-2, and
Ad5 E1B 19K. The Gene Inspector program (Textco) was used to perform a dot
matrix analysis of SV40 Tag and Ad5 E1B 19K for amino acid sequence simi-
larity. The region shown had by far the greatest homology and corresponds to the
same region of E1B 19K which shows significant homology to the BH-1 domain
of human Bcl-2. Boxed amino acids represent amino acids that are identical or
conserved among the three proteins.
FIG. 6. (A) Immunoprecipitation of 35S-labeled cell extracts from early-pas-
sage REF-52 cell lines expressing wild-type (WT) or mutant Tags containing
changes at aa 528 or 539. Cells were labeled with [35S]methionine, and Tag was
immunoprecipitated with MAb 419. (B) Viability of early-passage REF-52 cells
expressing inA409 (inA2409) or inA424 (inA2411) mutant Tags with additional
mutations at aa 528 or 539. Viability was determined for adherent and floating
cells by trypan blue exclusion. The experiment was repeated with multiple indi-
vidually derived REF-52 cell lines for each mutant, with similar results.
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types, it is expressed at higher levels during p53-induced apo-
ptosis (16, 29). However, in our studies, we saw no significant
difference in Bax levels in REF-52 clones expressing either
wild-type Tag (Fig. 4C, lane 1), mut(p532)Tags (lanes 2 and 3),
or N-termTags (lanes 4 to 6). Taken together, the results to
examine expression of p53, p21Waf1/Cip1, and Bax suggest that
a p53-independent mechanism may play a role in SV40 Tag-
induced apoptosis.
Amino acids 528 and 539 of Tag are critical for preventing
apoptosis induced by N-termTags. Alignment of SV40 large
and small T antigens with the Ad5 E1B 19K amino acid se-
quences was performed in order to identify sequences in SV40
large T or small t antigen which might be homologous to
critical sequences in E1B 19K and might possess antiapoptotic
activity. Dot matrix analyses using the Gene Inspector program
(Textco, Inc., West Lebanon, N.H.) revealed that the region
with the greatest sequence similarity between SV40 antigens
and the Ad5 E1B 19K protein corresponds to aa 525 to 541 of
SV40 Tag and aa 77 to 93 of Ad5 E1B 19K (Fig. 5). Interest-
ingly, this region of Ad5 E1B 19K has been previously identi-
fied as homologous to the Bcl-2 family’s BH-1 domain; both
regions appear essential for efficient protection from apoptosis
(4). Although the conserved glycine of BH-1 is not present in
SV40 Tag, flanking amino acids show .60% homology with
E1B 19K and Bcl-2. Since aa 525 to 541 are not required for
p53 binding and do not affect the transformation efficiency of
Tag (12, 21, 44), we reasoned that the conserved residues may
be critical for preventing apoptosis by a mechanism indepen-
dent of direct sequestration of p53. To examine the role of this
region in inhibiting apoptosis, site-directed mutagenesis was
performed to change the methionine at aa 528 of SV40 Tag to
a serine (528MS) and the alanine at aa 539 to aspartic acid
(539AD) (Fig. 5); similar mutations in the corresponding po-
sitions in E1B 19K have been shown previously to render this
protein defective for its antiapoptotic function (7). These mu-
tations were introduced into both wild-type Tag and the p53
nonbinding Tags inA2809/inA409 and inA2811/inA424.
Stable early-passage clones of REF-52 cells which expressed
these new mutant Tags were generated. Expression of Tags of
the expected size in individual cell clones was confirmed by
both Western analysis (data not shown) and immunoprecipi-
tation of 35S-labeled cell extracts, using the anti-Tag MAb 419
(Fig. 6A). Mutant proteins were consistently expressed at lev-
els that were equal to or at least one-third of that of wild-type
Tag. Figure 6B shows the results of a trypan blue dye exclusion
assay of cellular viability of these cell lines grown in low serum
(0.5%) and demonstrates that mutation of either aa 528 or aa
539, in the context of a full-length Tag which cannot bind p53,
substantially decreased cell viability. Surprisingly, we found
that mutations at the same sites but in a wild-type Tag back-
ground (producing proteins which are able to bind p53 and
morphologically transform cells) also significantly decreased
the percentage of viable cells when cultured in low serum (Fig.
6B). Since the WT/528AS and WT/539AD mutant Tags con-
tain all three regions necessary for immortalization and trans-
formation (including the p53 binding region), expression of
these mutants is likely to result in a high percentage of abnor-
mally cycling cells. It is probable that this population of aber-
rantly cycling cells is vulnerable to p53-independent apoptosis,
accounting for the low viability of WT/528AS- and WT/
539AD-expressing cells in low serum.
To confirm that the decreased viability of REF-52 cells was
due to apoptotic cell death, cells expressing these mutant Tags
were evaluated by using DAPI staining (to assess nuclear
morphology) and by in situ dUTP-FITC incorporation, or
TUNEL (terminal deoxynucleotidyltransferase-mediated
dUTP-biotin end labeling) assay (to estimate the extent of
cellular DNA fragmentation). DAPI and TUNEL analysis
showed few apoptotic cells in REF-52 cells expressing inA409,
inA424, and wild-type Tag (Fig. 7a, b, g, h, m, and n), while
FIG. 7. In situ detection of apoptosis in REF-52 cell lines stably expressing Tags containing mutations altering aa 528 or 539. Early-passage REF-52 cell lines stably
expressing truncated or full-length mutant Tags with or without additional mutations at aa 528 or 539 are shown after incubation in DMEM–0.5% FCS for 4 days. DAPI
staining shows nuclear morphology of apoptotic cells. For the in situ detection of DNA fragmentation (TUNEL assay), FITC-conjugated antidigoxigenin antibody was
used to detect DNA fragments end labeled with digoxigenin-dUTP (magnification, 3400).
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cells expressing the mutation at aa 528 (Fig. 7c, d, i, j, o, and p)
or 539 (Fig. 7e, f, k, l, q, and r) consistently showed more
apoptosis by evaluation of both nuclear morphology and
TUNEL staining.
DISCUSSION
Viruses appear to have evolved mechanisms to prevent or
delay cell death in infected cells, thus ensuring an adequate
time frame for viral DNA replication and production of prog-
eny virions (40). Both p53-dependent and p53-independent
forms of apoptosis appear to function in many systems. For
example, when cells are infected by human adenoviruses, p53
is required to mediate apoptosis in response to expression of
E1A in certain cell types (see reference 40 for a review);
however, it is becoming increasingly clear that p53-indepen-
dent mechanisms of adenovirus-induced apoptosis also exist
(33, 36). The physiological relevance of p53 mutation or dele-
tion in protecting mammalian cells from apoptosis and in tu-
mor development has been confirmed in several systems by
either functional inactivation of p53 or the genetically engi-
neered absence of p53 (17, 23, 35). However, in addition to
functional inactivation of p53 through the formation of com-
plexes between p53 and either the adenovirus E1B 55K (4) or
the E4orf6 protein (14), adenoviruses also express a powerful
antiapoptotic E1B 19K gene product which may work through
both p53-dependent and p53-independent mechanisms (40). In
fact, in some cell types, including primary baby rat kidney
epithelial cells, sequestration of p53 by E1B 55K alone does
not prevent apoptosis in the absence of E1B 19K expression
(28). Similarly, E1B 55K is unable to block p53-independent
E1A-induced apoptosis, while E1B 19K significantly over-
comes this process (22). Thus, E1B 19K function may comple-
ment p53 sequestration and thereby enhance the antiapoptotic
defenses of the adenoviruses.
In this work, we have identified an antiapoptotic region of
Tag which prevents apoptosis in the context of wild type WT
Tag and therefore appears to function independently of se-
questration of p53 by Tag. Furthermore, the fact that muta-
tions at aa 528 or 539 permitted apoptosis even in a fully
transforming wild-type Tag background suggests that escape
from apoptosis is not necessarily required for development of
a transformed phenotype. Indeed, we found that the frequency
of focus-forming colonies was approximately the same for wild-
type Tag and mutants WT/528MS and WT/537AD (10), yet the
cell lines expressing these mutant Tags exhibited diminished
viability in low serum. Analogous observations have been made
with E1A/Ras-transformed (18) and c-Myc-transformed MEFs
(39), which, in low serum, undergo dramatic apoptosis even
though surviving cells maintain a transformed phenotype. Sim-
ilarly, primary baby rat kidney cells expressing E1A and E1B
55K (which binds to p53) without E1B 19K form dense foci
characteristic of transformation but at low serum concentra-
tions also exhibit a loss of viability associated with the hallmark
changes of apoptosis (28). Thus, oncogene expression and/or
tumor suppressor inactivation sufficient for the morphological
transformation of cells does not necessarily preclude signifi-
cant apoptosis. Conversely, we have shown by expression of
mut(p532)Tags in primary rodent cells and REF-52 cells that
protection from apoptosis does not necessarily result in trans-
formation. Thus, transformation and protection from apopto-
sis are likely to involve overlapping but distinct pathways of
oncogene activity and tumor suppressor gene inactivation.
SV40 Tag’s antiapoptotic region also appears to prevent
E1A-induced apoptosis in primary cells. We stably coexpressed
a mut(p532)Tag (mutant inA2811) with E1A in primary MEFs
and found that colony regression and apoptosis are prevented
(10). Protection from E1A-induced apoptosis was not seen
with N-termTags or if the antiapoptotic region was mutated.
This finding suggests that the antiapoptotic domain of SV40
Tag may work through a generalized p53-independent path-
way.
The newly identified antiapoptotic region of SV40 Tag, al-
though it does not contain the conserved glycine of BH-1, has
.60% homology with the BH1 region of the Bcl-2 family.
BH-1 is necessary, but not sufficient, for Bax interaction (43).
Using nonstringent immunoprecipitation conditions, we have
been unable to demonstrate an in vivo interaction between Tag
and Bax (10), consistent with the requirement for the con-
served glycine for Bax interaction (5). Thus, the mechanism by
which SV40 Tag is able to prevent apoptosis independently of
p53 binding remains to be determined. However, the relevance
of SV40 Tag-induced apoptosis in the presence of wild-type
p53 and transformation is underscored by the recent discovery
of high levels of apoptosis in the early stages of a transgenic
SV40 Tag-induced pancreatic carcinoma model (24). In this
model, Tag-induced apoptosis appears to be independent of
p53 expression since similar levels of cell death were observed
in a p532/2 background and a p531/1 strain. The modulation
of apoptosis may instead involve the changing interactions of
SV40 Tag with cellular proteins involved in triggering or pro-
tecting cells from apoptosis. Whether the region that we have
identified is involved in regulating the levels of apoptosis seen
in early and late tumors in the transgenic pancreatic carcinoma
model system remains to be determined. However, the molec-
ular characterization of SV40 Tag’s interactions with cellular
antiapoptotic proteins may yield clues to the complex mecha-
nisms modulating oncogene-induced apoptosis and transfor-
mation.
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